<DOC>
	<DOCNO>NCT01164540</DOCNO>
	<brief_summary>This study evaluate whether treatment rosuvastatin top standard anti-coagulant treatment decrease risk recurrent venous thromboembolism arterial thromboembolic event patient previous deep vein thrombosis pulmonary embolism .</brief_summary>
	<brief_title>Study Effect Rosuvastatin Treatment Prevention Thrombosis Patients With Previous Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Signed informed Consent . Patients venous thromboembolism treat anticoagulant accord current guideline Patients need already treat lipid lower drug Active liver kidney disease dysfunction muscle disorder Unstable medical psychological condition interferes study participation Pregnant woman woman childbearing potential willing use contraception History statinrelated muscular pain , hypersensitivity statin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Deep venous thrombosis</keyword>
	<keyword>Pulmonary embolism</keyword>
	<keyword>rosuvastatin treatment</keyword>
</DOC>